ANI Pharmaceuticals Inc · Brief

Next report

9 days

Nov 9 · before openest.Q3 FY26

Expected move

No implied move.

8 reportsHistory

1 of 8≥ implied

Aug 8 '25±9.5%▲+18.07%×1.90

Q3 FY25±5.3%▼−0.16%×0.03

Nov 7 '25±7.7%▲+0.22%×0.03

Nov 10 '25±5.3%▼−1.66%×0.32

Jan 12 '26±5.0%▼−2.45%×0.49

Q1 FY26±11.5%▼−4.21%×0.36

May 8 '26±8.2%▼−2.44%×0.30

Q2 FY26±8.4%▼−5.30%×0.63

quarterimplied−20%0+20%realized×

Q2 FY26±8.4%▼−5.30%×0.63

May '26±8.2%▼−2.44%×0.30

Q1 FY26±11.5%▼−4.21%×0.36

Jan '26±5.0%▼−2.45%×0.49

Nov '25±5.3%▼−1.66%×0.32

Nov '25±7.7%▲+0.22%×0.03

2 older reports

Q3 FY25±5.3%▼−0.16%×0.03

Aug '25±9.5%▲+18.07%×1.90

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 9 report · est.

Bull1

33disclosed supplier and customer ties in SEC filingsSEC filings

Bear2 of 3

7 of 8recent reports where the move came in under the options-implied rangeEarnings history

3tracked funds holding ANIPN-PORT · Aug 31 '26

AI captions · Sep 16 '26once per report · top 2 per case

ANIP report session

No linked exposure.

Oct 26impliedImplied move: ±8.8% into Nov 9 earnings (Oct 26 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.